Abstract:Finding drug-like compounds with high bioactivity is essential for drug discovery, but the task is complicated by the high cost of chemical synthesis and validation. With their outstanding performance in de novo drug design, deep generative models represent promising tools for tackling this challenge. In recently years, 3D molecule generative models have gained increasing attention due to their ability to directly utilize the 3D interaction information between the target and ligand. However, it remains challenging to synthesize the molecules generated by these models, limiting the speed of bioactivity validation and further structure optimization. In this work, we propose DeepLigBuilder+, a deep generative model for 3D molecules that combines structure-based de novo drug design with a reaction-based generation framework. Besides producing 3D molecular structures, the model also proposes synthetic pathways for generated molecules, which greatly assists the retro-synthetic analysis. To achieve this, we developed a new way to enforce the synthesizability constraint using a tree-based organization of purchasable building blocks. This method enjoys high scalability and is compatible with existing atom-based generative models. Additionally, for structure-based design tasks, we developed an SE(3)-equivariant transformer conditioned on the shape and pharmacophore-based inputs, and combine it with the Monte Carlo tree search. Using the ATP-binding pocket of BTK and the NAD+ binding pocket of PHGDH for case studies, we demonstrate that DeepLigBuilder+ is capable of enriching drug-like molecules with high predicted binding affinity and desirable interaction modes while maintaining the synthesizability constraint. We believe that DeepLigBuilder+ is a powerful tool for accelerating the process of drug discovery.

ChemistGA: A Chemical Synthesizable Accessible Molecular Generation Algorithm for Real-World Drug Discovery

Advances in Deep Learning-Based 3D Molecular Generative Models

Genetic Algorithm-Based Receptor Ligand: A Genetic Algorithm-Guided Generative Model to Boost the Novelty and Drug-Likeness of Molecules in a Sampling Chemical Space.

Towards Exploring Large Molecular Space: an Efficient Chemical Genetic Algorithm.

Generative chemistry: drug discovery with deep learning generative models

A Transformer-based Generative Model for De Novo Molecular Design

Comprehensive assessment of deep generative architectures for de novo drug design

DrugSynthMC: an atom based generation of drug-like molecules with Monte Carlo Search

AnoChem: Prediction of chemical structural abnormalities based on machine learning models

Deep Generative Models in De Novo Drug Molecule Generation

Molecular design in drug discovery: a comprehensive review of deep generative models

Molecular Design in Synthetically Accessible Chemical Space via Deep Reinforcement Learning

Optimizing Drug Design by Merging Generative AI With Active Learning Frameworks

Unlocking comprehensive molecular design across all scenarios with large language model and unordered chemical language

SynthFormer: Equivariant Pharmacophore-based Generation of Molecules for Ligand-Based Drug Design

ClickGen: Directed Exploration of Synthesizable Chemical Space Via Modular Reactions and Reinforcement Learning

Machine learning-aided generative molecular design

Synthesis-driven design of 3D molecules for structure-based drug discovery using geometric transformers

DockingGA: enhancing targeted molecule generation using transformer neural network and genetic algorithm with docking simulation

Target-aware Molecular Graph Generation

Molecular Generative Model via Retrosynthetically Prepared Chemical Building Block Assembly